Skip to main content
Premium Trial:

Request an Annual Quote

Broad Lab to Sequence Lassa Viruses for NIAID

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - The Broad Institute at Harvard and MIT will use funding from the National Institute of Allergy and Infectious Diseases to conduct whole-genome sequencing of the virus that causes Lassa fever, an acute hemorrhagic fever endemic in West Africa that is being watched by the US Centers for Disease Control and Prevention as a potential bioterrorism threat.

The rat-borne Lassa virus kills between 15 and 20 percent of people who are hospitalized with the fever, according to CDC. During epidemics, however, the fatality rate can reach 50 percent.

Broad researchers in the lab of Pardis Sabeti, an assistant professor at the Center for Systems Biology at Harvard, will use around $1.5 million in funding over five years to conduct whole-genome sequencing of hundreds and thousands of Lassa genomes, Sabeti told GenomeWeb Daily News today in an e-mail.

The funding from NIAID is part of a collaboration with Tulane University, which received a $15 million grant to study the virus and develop new therapeutics to treat and prevent the sickness it causes.

Aside from the Sabeti lab, other partners in the Tulane-led Lassa project include Scripps Research Institute, the University of California at San Diego, Boston University, Autoimmune Partners, Corgenix Medical Corp., as well as partners in West Africa.

The $15 million grant to Tulane is the third grant it has received for its ongoing Lassa studies.

"The diagnostic products we have developed have been shown to be remarkably effective in clinical settings in Africa, and will not only have a meaningful impact on health care in that part of the world, but will also fill a critical gap in bioterrorism defense," Robert Garry, a Tulane professor and program manager on the contract, said in a statement.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.